超越生长激素:矮小症类型与生长激素和脊柱侧弯的关联
横断面与回顾性队列研究纳入3896例矮小症患者(部分性生长激素缺乏、生长激素缺乏、特发性矮小)及1:1年龄性别匹配对照,矮小症患者脊柱侧弯发生率高于对照,重组人生长激素治疗增加脊柱侧弯发生风险,维生素D补充可能有益于预防。
要点
- 部分性生长激素缺乏、生长激素缺乏、特发性矮小患者脊柱侧弯发生率均高于对照。
- 重组人生长激素治疗增加各矮小症组脊柱侧弯发生风险。
- 维生素D补充对脊柱侧弯发生有保护作用。
核心结论
- 应更加关注部分性生长激素缺乏、生长激素缺乏或特发性矮小患者的脊柱弯曲。
- 接受重组人生长激素治疗的矮小症患者脊柱侧弯发生风险增加。
- 维生素D补充可能有益于预防脊柱侧弯。
研究设计与样本
- 横断面与回顾性队列研究,横断面部分纳入3896例矮小症患者(部分性生长激素缺乏、生长激素缺乏、特发性矮小)及1:1年龄性别匹配的对照,对照有既往全脊柱X线片。
- 队列研究纳入2605例接受两次以上X线检查的受试者,评估脊柱侧弯发生、进展及支具和手术需求。
- 采用校正逻辑回归评估脊柱侧弯患病率差异,Kaplan-Meier法分析脊柱侧弯发生和进展的时间进程,Cox回归评估相关独立因素,并进行了孟德尔随机化分析。
主要发现
- 与对照相比,矮小症患者脊柱侧弯发生率更高:部分性生长激素缺乏组34.47%、生长激素缺乏组31.85%、特发性矮小组32.94% vs 对照组8.83%,P<0.001。
- 与对照相比,矮小症患者脊柱侧弯发生风险更高:部分性生长激素缺乏组HR=1.964(P<0.001)、生长激素缺乏组HR=1.881(P=0.001)、特发性矮小组HR=1.706(P=0.001),但进展、支具或手术风险未升高。
- 三种矮小症类型之间,脊柱侧弯发生率、发生、进展及支具或手术需求无差异。
- 重组人生长激素治疗增加各矮小症组脊柱侧弯发生风险:部分性生长激素缺乏组HR=2.673(P<0.001)、生长激素缺乏组HR=1.924(P=0.049)、特发性矮小组HR=1.564(P=0.004)。
- 维生素D补充对脊柱侧弯发生有保护作用:部分性生长激素缺乏组HR=0.456(P=0.003)、生长激素缺乏组HR=0.42(P=0.013)、特发性矮小组HR=0.838(P=0.257)。
临床怎么用
- 作者认为,应更加关注部分性生长激素缺乏、生长激素缺乏或特发性矮小患者的脊柱弯曲。
- 作者认为,接受重组人生长激素治疗的矮小症患者脊柱侧弯发生风险增加。
- 作者认为,维生素D补充可能有益于预防脊柱侧弯。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Cross-sectional and retrospective cohort study. OBJECTIVE: We investigated the effect of 3 types of short stature [partial growth hormone deficiency (GHD), GHD, and idiopathic short stature (ISS)] and recombinant human growth hormone (rhGH) therapy on scoliosis. SUMMARY OF BACKGROUND DATA: In short stature, rhGH is widely used and the concentration of growth hormone varies among types. The epidemiologic characteristics of scoliosis and the role of rhGH in scoliosis remain unclear. PATIENTS AND METHODS: A cross-sectional study was conducted among 3896 patients with short stature (partial GHD, GHD, and ISS), and a 1:1 age and sex-matched control group with preexisting whole-spine radiographs. The cohort study included 2605 subjects who underwent radiography more than twice to assess scoliosis development, progression, and the need for bracing and surgery. Adjusted logistic regression was used to assess differences in the prevalence of scoliosis among patients with partial GHD, GHD, ISS, and controls. The Kaplan-Meier method was used to analyze the time course of scoliosis development and progression. Cox regression was applied to assess the independent factors related to scoliosis development and progression. Mendelian randomization analyses were also performed. RESULTS: Compared with controls, patients with short stature had a higher incidence of scoliosis (34.47% in partial GHD, 31.85% in GHD, 32.94% in ISS vs . 8.83% in control, P < 0.001), a higher risk of scoliosis development [hazard ratio (HR) = 1.964 in partial GHD, P < 0.001; HR = 1.881 in GHD, P = 0.001; HR = 1.706 in ISS, P = 0.001), but not a higher risk of progression, brace, or surgery. Among the 3 types of short stature, there were no differences in the incidence, development, and progression of scoliosis or the need for bracing or surgery. RhGH treatment increased the risk of scoliosis development in each short-stature group (HR = 2.673 in partial GHD, P < 0.001; HR = 1.924 in GHD, P = 0.049; HR = 1.564 in ISS, P = 0.004). Vitamin D supplementation was protective against scoliosis development (HR = 0.456 in partial GHD, P = 0.003; HR = 0.42 in GHD, P = 0.013; HR = 0.838 in ISS, P = 0.257). CONCLUSIONS: More attention should be paid to the spinal curve in patients with partial GHD, GHD, or ISS. For short stature treated with rhGH, the risk of scoliosis development was increased. Vitamin D supplementation may be beneficial for prevention. LEVEL OF EVIDENCE: Level III.
引用
- Hong H, Hu J, Xu H, et al. Beyond Growth Hormone: Association of Short Stature Types and Growth Hormones With Scoliosis. Spine (Phila Pa 1976). 2023. PMID: 37871182. doi:10.1097/BRS.0000000000004853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。